© 2022 Turkish Society of Nephrology. All rights reserved.Objective: The Turkish Society of Nephrology Registry collects data on hemodialysis, peritoneal dialysis, and transplantation annually. Registry reports are printed every year as a booklet, and this is the 30th year of registry reports. Unlike previous years, registry reports include an additional chapter this year due to the Coronavirus Disease 2019 (COVID-19). The effects and results of the COVID-19 pandemic on kidney replacement therapies are presented in the 2020 reports. Methods: In this article, we obtained data from the Turkish Society of Nephrology 2020 registry report and summarized the coronavirus disease 2019-associated data and statistics for kidney failure with replacement therapy patients. Results: The number of patients on kidney replacement therapies was 83 350 individuals at the end of 2020. Totally, 1610 kidney replacement therapy patients were infected with severe acute respiratory syndrome coronavirus 2. Hemodialysis had the highest frequency of coronavirus disease 2019 (19.5%), followed by transplantation (12.2%) and peritoneal dialysis (8.6%). The mortality rate was highest in peritoneal dialysis patients with 29.6%, 24.4% in hemodialysis, and 11.2% in kidney transplant recipients. Conclusions: Coronavirus disease 2019 has significant effects on the survey of patients undergoing kidney replacement therapies through severe complications.